Association study of CRP gene and ischemic stroke in a Chinese Han population

Chong Shen1, Xiaoyang Sun, Hairu Wang

  • 1Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, 210029, China.

Insights

Genetic variations in C-reactive protein (CRP) are linked to a reduced risk of ischemic stroke and elevated hsCRP levels. These findings suggest a connection between CRP gene polymorphisms and stroke, warranting further investigation.

Area of Science:

  • Genetics
  • Cardiovascular Disease Epidemiology
  • Biomarkers

Background:

  • High-sensitivity C-reactive protein (hsCRP) is a known predictor of myocardial infarction and stroke.
  • Understanding the relationship between CRP genetic variations, plasma hsCRP levels, and cerebral events is crucial.

Purpose of the Study:

  • To investigate the association between CRP gene polymorphisms, plasma hsCRP levels, and the risk of acute ischemic stroke.
  • To explore the link between CRP genetic variations and hsCRP elevation in stroke patients and controls.

Main Methods:

  • A case-control study involving 548 ischemic stroke patients and 993 controls.
  • Genotyping of four tagging single nucleotide polymorphisms (tagSNPs) in the CRP gene.
  • Logistic regression analysis to assess associations, adjusting for covariates.

Main Results:

  • rs3093059 and rs3091244 showed statistical associations with a decreased risk of ischemic stroke.
  • No significant differences in SNP frequencies were found between hypertension and normal blood pressure groups.
  • Genetic variations (rs876537, rs3093059) were associated with elevated hsCRP in stroke patients, while (rs876537, rs3091244) were associated with elevated hsCRP in controls.

Conclusions:

  • CRP genetic polymorphisms are associated with a reduced risk of ischemic stroke.
  • These genetic variations may also be linked to elevated plasma hsCRP levels.
  • Further replication and functional studies are recommended to confirm these findings.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...